InBioGen Co Ltd (101140) — Cash Flow Reinvestment Rate

Latest as of December 2024: 0.09x

InBioGen Co Ltd (101140) has a Cash Flow Reinvestment Rate of 0.09x as of December 2024, reinvesting ₩117.75 Million (capex ₩60.00 Million plus investments ₩-57.75 Million) from operating cash flow of ₩1.36 Billion. Check 101140 cash flow quality index to evaluate the quality of earnings relative to operating cash generation.

Reinvestment Rate

0.09x
(Capex + Investments) / Operating CF

Total Reinvested

₩117.75 Million
Capex + Investments

Operating Cash Flow

₩1.36 Billion
KRW

Capital Expenditures

₩60.00 Million
KRW

InBioGen Co Ltd Cash Flow Reinvestment Rate (2016–2016)

Historical reinvestment intensity for InBioGen Co Ltd across 1 annual periods. Explore 101140 long-term asset investment ratio to see how much of total assets are deployed in long-term investments.

Annual Cash Flow Reinvestment Rate for InBioGen Co Ltd (2016–2016)

Year-by-year capital reinvestment analysis for InBioGen Co Ltd. For live market cap and broader valuation context, see 101140 company net worth.

Year Reinvestment Rate Total Reinvested (KRW) Operating CF Capex YoY Change
2016 0.03x ₩8.98 Million ₩344.75 Million ₩0.00 —
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow